JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2016, 65(2):78-81 | DOI: 10.36290/csf.2016.014

The evaluation of the prevalence of constipation at the Centre of clinical gerontology

Pavla Pančevová1,2,*, Martin Vodička1,2, Karel Vašut1,2, Milan Forejtar1,2
1 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav aplikované farmacie
2 Krajská nemocnice Tomáše Bati a. s. Zlín, Centrum klinické gerontologie (LDN), Zlín

Constipation is a disease which increases in the senior population and is a common complication for hospitalised patients. Among the risk factors are age, female gender, immobility, diet, fluid intake and polypharmacotherapy. The aim of the study was to analyse the prevalence of constipation according to the used drugs and known risk factors in a population with a high prevalence of constipation. In the department of clinical gerontology, observational prevalence point study was performed using a questionnaire involving 100 patients based on the patient's subjective perception of constipation. Prevalence of constipation was determined according to the drug categories and individual drugs, gender, age, mobility, diagnosis, diet and fluid intake. There were 59 patients who suffered from constipation. A high prevalence of constipation was associated with the diet, the principal diagnosis, and mainly the use of drugs. Among the drugs associated with constipation were the calcium channel blockers of 21 patients out of 28, HMG-CoA reductase inhibitors of 22 patients out of 30, drugs for the treatment of increased urinary frequency and incontinence of 6 patients out of 6 and bisoprolol of 10 patients out of 11. Hospitalisation of seniors is connected with the high prevalence of constipation that is increased by the use of drugs that influence constipation. A change in the therapeutic value of drugs should be taken into consideration during the pharmacotherapy of this group of patients.

Keywords: constipation; risks factors for constipation; drug-induced constipation

Received: February 1, 2016; Accepted: February 16, 2016; Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pančevová P, Vodička M, Vašut K, Forejtar M. The evaluation of the prevalence of constipation at the Centre of clinical gerontology. Čes. slov. farm. 2016;65(2):78-81. doi: 10.36290/csf.2016.014.
Download citation

References

  1. Fosnes G. S., Lydersen S., Farup P. G. Constipation and diarrhoea - common adverse drug reactions? A cross sectional study in the general population. BMC Clinical Pharmacology 2011; 11, 2. Go to original source... Go to PubMed...
  2. Peppas G., Alexiou V. G., Mourtzoukou E., Falagas M. E. Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterology 2008; 8, 5. Go to original source... Go to PubMed...
  3. Andromanakos N., Skandalakis P., Troupis T., Filippou D. Constipation of anorectal outlet obstruction: Pathophysiology, evaluation and management. Journal of Gastroenterology and Hepatology 2006; 21(4), 403-412. Go to original source... Go to PubMed...
  4. Gallagher P., O'Mahony D. Constipation in old age. Best Practice & Research Clinical Gastroenterology 2009; 23(6), 875-887. Go to original source... Go to PubMed...
  5. van Dijk K. N, De Vries C. S., Van den Berg P. B., Dijkema A. M., Brouwers J. R., De Jong-Van den Berg L. T. Constipation as an adverse effect of drug use in nursing home patients: an overestimated risk. British Journal of Clinical Pharmacology 1998; 46(3), 255-261. Go to original source... Go to PubMed...
  6. Gandell D., Straus S. E., Bundookwala M., Tsui V., Alibhai S. M. Treatment of constipation in older people. Canadian Medical Association Journal 2013; 185(8), 663-670. Go to original source... Go to PubMed...
  7. Talley N. J., Jones M., Nuyts G., Dubois D. Risk factors for chronic constipation based on a general practice sample. The American Journal of Gastroenterology 2003; 98(5), 1107-1111. Go to original source... Go to PubMed...
  8. Namirah J., Zone-en L., Olden K. Diagnostic approach to chronic constipation in adults. American Family Physician 2011; 84(3), 299-306. Go to original source...
  9. Folstein M. F., Robins L. N., Helzer J. E. The Mini-Mental State Examination. Archieves General Psychiatry 1983; 40(7), 812. Go to original source... Go to PubMed...
  10. Wade D. T., Collin C. The Barthel ADL Index: A standard measure of physical disability? Disability and Rehabilitation 1988; 10(2), 64-67. Go to original source... Go to PubMed...
  11. Lee J., Chia K. S. Use of the prevalence ratio v the prevalence odds ratio as a measure of risk in cross sectional studies. Occupational and Environmental Medicine 1994; 51(12), 841. Go to original source... Go to PubMed...
  12. Richmond J. P., Wright M. E. Review of the literature on constipation to enable development of a constipation risk assessment scale. Clinical Effectiveness in Nursing 2004; 8(1), 11-25. Go to original source...
  13. Suares N., Ford A. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. The American Journal of Gastroenterology 2011; 106, 1582-1591. Go to original source... Go to PubMed...
  14. Higgins P. D., Johanson J. F. Epidemiology of constipation in North America: A systematic review. The American Journal of Gastroenterology 2004; 99(4), 750-759. Go to original source... Go to PubMed...
  15. McCrea L. G., Miaskowski C., Stotts N., Macera L., Varma M. G. A review of the literature on gender and age differences in the prevalence and characteristics of constipation in North America. Journal of Pain and Symptom Management 2009; 37(4), 737-745. Go to original source... Go to PubMed...
  16. Topinková E., Fialová D., Matějovská-Kubešová H., Ballóková A. Potenciálně nevhodná (riziková) léčiva u seniorů: Expertní konsensus pro Českou republiku 2012. Praktické lékárenství 2012; 92(1), 11-22.
  17. Bassotti G., Calcara C., Annese V., Fiorella S., Rosseli P., Morelli A. Nifedipine and verapamil inhibit the sigmoid colon myoelectric response to eating in healthy volunteers. Disease of the Colon & Rectum. 1998; 41(3), 377-380. Go to original source... Go to PubMed...
  18. Müller-Lissner S. A., Kamm M. A., Scarpignato C., Wald A. Myths and misconceptions about chronic constipation. The American Journal of Gastroenterology 2005; 100(1), 232-242. Go to original source... Go to PubMed...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.